NOK Therapeutics, Inc. — Regulation A 1-A/A
NOK Therapeutics, Inc. of Cranberry Twp, PA filed a Regulation A 1-A/A with the SEC on 2024-11-25. Aggregate offering: $10.0M (Tier 1). Industry: Other.
Offering
- Filed: 2024-11-25
- Form: 1-A/A
- Accession: 0001213900-24-102085
- Tier: Tier 1
- Total aggregate offering: $10.0M
- Issuer portion: $10.0M
- Price per security: $2.0000
- Securities offered: Equity (common or preferred stock)
- Audit status: Unaudited
- Auditor: Astra Audit and Advisory, LLC. Period from Inception (May 22, 2024) to June 30, 2024 Audited
- Jurisdictions: 52 states/territories
Issuer
- CIK: 0002038166
- Organized in: FL
- Incorporated: 2024
- Address: 2009 Mackenzie Way, Cranberry Twp, PA, 16066
- Phone: 888-691-5839
- Employees: 4 part-time
Financial snapshot (as filed)
- Total assets: $12K
- Cash & equivalents: $12K
- Total liabilities: $173K
- Stockholder equity: $-161K
- Net income: $-163K
People (1)
| Name | Role | Location |
|---|
| Jim Byrd | Signer | Houston, TX |
Other Reg A filings by this issuer (8)
More